Loading company…
Sonio develops medical software for fetal anomaly diagnosis and prenatal screening.
Sonio provides AI-based SaaS software to assist with fetal anomaly diagnosis and associated syndromes, as well as software for prenatal screening and fetal ultrasound. Based in Paris, France, the company raised EUR 13 million in Series A funding in July 2023, co-led by Cross-Border Impact Ventures and Elaia Partners, with participation from OneRagtime and individual investors.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in